A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

China: A new meta-analysis published in Annals of Medicine has identified elevated C-reactive protein (CRP) levels as a ...

The Christie NHS Foundation Trust together with the Cancer Research UK National Biomarker Centre and The University of ...

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

Like other cancers, melanoma is rising among young adults. It's now the 2nd most common cancer in 15 to 39 year-olds.

TIL-IMP therapy offers sustained QoL benefits over ipilimumab in advanced melanoma, supporting its role in personalized care.

A new study led by researchers at Lund University in Sweden reveals that melanoma can, in some cases, be driven by ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Pathologists' examinations of tissue samples from skin cancer tumors improved when they were assisted by an AI tool. The ...

Researchers have discovered that the most aggressive melanomas, the deadliest form of skin cancer, overactivate two key ...